![U.S. - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights](/landing/img/reports/u-s-medicaments-containing-insulin-but-not-antibiotics-in-measured-doses-market-analysis-forecast-size-trends-and-insights.webp)
U.S. - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPrice for Prophylactic Medicaments Containing Insulin in the United States - 2023
Contents:
- Price for Prophylactic Medicaments Containing Insulin in the United States (CIF) - 2023
- Price for Prophylactic Medicaments Containing Insulin in the United States (FOB) - 2023
- Imports of Prophylactic Medicaments Containing Insulin in the United States
- Exports of Prophylactic Medicaments Containing Insulin in the United States
Price for Prophylactic Medicaments Containing Insulin in the United States (CIF) - 2023
In September 2023, the average prophylactic medicaments containing insulin import price amounted to $261K per ton, falling by -7.7% against the previous month. Overall, the import price recorded a relatively flat trend pattern. The pace of growth was the most pronounced in December 2022 when the average import price increased by 49% against the previous month. As a result, import price reached the peak level of $320K per ton. From January 2023 to September 2023, the average import prices remained at a lower figure.
Prices varied noticeably by the country of origin: the country with the highest price was Italy ($444K per ton), while the price for Malaysia ($93,774 per ton) was amongst the lowest.
From September 2022 to September 2023, the most notable rate of growth in terms of prices was attained by Italy (+8.9%), while the prices for the other major suppliers experienced mixed trend patterns.
Price for Prophylactic Medicaments Containing Insulin in the United States (FOB) - 2023
The average prophylactic medicaments containing insulin export price stood at $438K per ton in September 2023, with an increase of 33% against the previous month. Overall, the export price showed a strong expansion. The pace of growth appeared the most rapid in August 2023 when the average export price increased by 118% against the previous month. Over the period under review, the average export prices attained the maximum in September 2023.
Prices varied noticeably by the country of destination: the country with the highest price was Mexico ($672K per ton), while the average price for exports to Spain ($25,977 per ton) was amongst the lowest.
From September 2022 to September 2023, the most notable rate of growth in terms of prices was recorded for supplies to Japan (+14.7%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Prophylactic Medicaments Containing Insulin in the United States
For the fourth year in a row, the United States recorded growth in supplies from abroad of medicaments containing insulin but not antibiotics in measured doses, which increased by 1.8% to 4.7K tons in 2022. The total import volume increased at an average annual rate of +8.6% over the period from 2019 to 2022; the trend pattern remained relatively stable, with somewhat noticeable fluctuations throughout the analyzed period. The most prominent rate of growth was recorded in 2020 with an increase of 14% against the previous year. Over the period under review, imports reached the maximum in 2022 and are expected to retain growth in the immediate term.
In value terms, prophylactic medicaments containing insulin imports dropped to $1.2B in 2022. Over the period under review, imports, however, continue to indicate a deep reduction. The most prominent rate of growth was recorded in 2021 with an increase of 1.5% against the previous year.
Import of Prophylactic Medicaments Containing Insulin in the United States (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
Germany | 1,386 | 1,140 | 1,082 | 870 | -14.4% |
France | 66.5 | 25.8 | 68.7 | 119 | 21.4% |
Denmark | 116 | 105 | 101 | 74.2 | -13.8% |
Malaysia | N/A | 18.7 | 64.3 | 72.3 | 96.6% |
Others | N/A | 6.7 | 0.1 | 34.1 | 125.6% |
Total | 1,569 | 1,296 | 1,316 | 1,170 | -9.3% |
Top Suppliers of Prophylactic Medicaments Containing Insulin to the United States in 2022:
- Germany (3439.6 tons)
- Malaysia (702.2 tons)
- France (355.1 tons)
- Denmark (199.9 tons)
Exports of Prophylactic Medicaments Containing Insulin in the United States
In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses increased by 59% to 3.4K tons for the first time since 2019, thus ending a two-year declining trend. Overall, total exports indicated a strong increase from 2019 to 2022: its volume increased at an average annual rate of +10.8% over the last three years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, the exports attained the peak and are likely to continue growth in the immediate term.
In value terms, prophylactic medicaments containing insulin exports surged to $537M in 2022. In general, exports recorded a significant expansion. As a result, the exports attained the peak and are likely to continue growth in the immediate term.
Export of Prophylactic Medicaments Containing Insulin in the United States (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
Canada | 31.1 | 85.2 | 113 | 170 | 76.2% |
Mexico | 42.2 | 47.1 | 68.2 | 144 | 50.6% |
Denmark | 7.1 | 5.3 | 12.9 | 46.4 | 87.0% |
Brazil | 27.5 | 24.2 | 11.8 | 44.1 | 17.0% |
Japan | 49.0 | 45.4 | 44.2 | 34.7 | -10.9% |
Spain | 34.8 | 26.2 | 27.1 | 30.3 | -4.5% |
Pakistan | 10.7 | 10.4 | 7.0 | 5.6 | -19.4% |
Argentina | 12.4 | 11.1 | 7.2 | 2.5 | -41.4% |
Colombia | 2.9 | 2.0 | 2.5 | 1.8 | -14.7% |
Others | 32.7 | 106 | 56.8 | 57.6 | 20.8% |
Total | 250 | 362 | 351 | 537 | 29.0% |
Top Export Markets for Prophylactic Medicaments Containing Insulin from the United States in 2022:
- Denmark (1184.4 tons)
- Japan (534.6 tons)
- Mexico (518.3 tons)
- Brazil (420.1 tons)
- Canada (195.6 tons)
- Spain (105.8 tons)
- Pakistan (98.5 tons)
- Colombia (37.1 tons)
- Argentina (22.3 tons)
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
- United States
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..
This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in the U.S..
This report provides an in-depth analysis of the medicaments containing vitamins market in the U.S..
This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in the U.S..
This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.
This report provides an in-depth analysis of the global market for medicaments containing corticosteroid hormones.
This report provides an in-depth analysis of the global medicaments containing vitamins market.
This report provides an in-depth analysis of the global market for penicillins or streptomycins medicaments.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..
This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in the U.S..
Explore the top import markets for prophylactic medicaments containing insulin, including key statistics and import values. Learn about the leading countries driving the demand for these essential healthcare products.
Discover the top import markets for medicaments containing corticosteroid hormones. Read about the import values and key statistics of the leading countries including the United States, Switzerland, China, and more.
Explore the top import markets for penicillins and streptomycins medicaments based on data from the IndexBox market intelligence platform.
Explore the top import markets for prophylactic medicaments containing insulin, including key statistics and import values. Learn about the leading countries driving the demand for these essential healthcare products.
Discover the top import markets for medicaments containing corticosteroid hormones. Read about the import values and key statistics of the leading countries including the United States, Switzerland, China, and more.
Explore the top import markets for penicillins and streptomycins medicaments based on data from the IndexBox market intelligence platform.